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Background
Opioid prescriptions in the United States have 
more than tripled from 1999-2014, during which 
there has been a staggering increase in opioid-
involved drug overdose deaths.  Providers need 
the means to objectively monitor analgesic 
efficacy of treatment in patients with pain to 
mitigate unnecessary prescriptions.  
It is well established that mu opioid receptor 
agonists like morphine cause miosis, an effect that 
does not exhibit tolerance. This suggests utility in 
investigating pupil size and responsiveness as 
pharmacokinetic measures of bioavailability. An 
infrared pupillometer is a device that produces a 
short light stimulus and subsequently measures 
parameters of the pupillary light reflex (PLR) 
including maximum and minimum pupil size 
(MAX, MIN), maximum constriction velocity 
(MCV), latency period before constriction onset 
(LAT), change in pupil size (DELTA), and average 
constriction velocity (ACV).  
Purpose
The goal of this study was to use infrared 
pupillometry to demonstrate the pattern of 
changes in PLR parameters before and after 
receiving low dose opioid analgesia.
Hypotheses
1. Patients receiving opioid analgesia will display 
differential parameters of their PLR before and after 
drug administration.
2. Opioid analgesics have a dose-dependent effect 
on parameters of the PLR. 
Methods
The Neuroptics PLR-2000 pupillometer was used to assess six pupillary parameters. Fifteen patients 
between the ages of 7 and 18 receiving low does opioids on patient controlled analgesia (PCA) were 
enrolled from the pain medicine service at Children’s National Medical Center.  
Patients were either post-surgical or admitted for sickle cell vaso-occlusive crisis.  Baseline PLR 
parameters were measured prior to PCA dose.  Two subsequent measurements were taken ten and 
fifteen minutes post PCA dose (figure 2).
Discussion
In concordance with previous research, the MIN is 
significantly correlated with opioid concentration 
dose-dependently across the 15-minute 
measurement window.  Current data support the 
efficacy of using infrared pupillometry to detect 
high dose opioid presence, but this research 
specifically demonstrates its efficacy in monitoring 
low dose therapeutic levels.
Establishing the pupillometer as a pharmacokinetic 
analog has many clinical applications. For example, 
genetic testing for polymorphisms that play a role 
in opioid metabolism (ex CYP2D6, OPRM1) can be 
eliminated.  More widespread applications include 
the continuous monitoring of patients’ opioid 
response to minimize unnecessary administration 
and to identify tolerance and hyperalgesia.
Next Steps
• Compare PLR parameters to blood levels of 
opioid metabolites to further support the 
efficacy of this novel pharmacokinetic measure
• Create an algorithm combining PLR data with 
pharmacodynamics--subjective pain scores-- to 
determine opioid sensitivity, tolerance, and 
hyperalgesia.
• Develop a noninvasive tool to objectively 
measure the analgesic effects of opioid 
medications.
Figure 2: Pupillary response to a light stimulus was compared before and after PCA administration
MAX MIN DELTA LAT ACV MCV
DFn, Dfd 1.222, 17.11
1.211, 
16.95
1.442, 
20.18
1.882, 
26.35
1.764,
24.70
1.934, 
27.08
F Statistic 11.68 10.3 1.775 3.746 2.326 3.414
p-Value 0.0021* 0.0036* 0.1989 0.0393* 0.1239 0.0490*
R2 0.4548 0.4239 0.1125 0.2111 0.7908 0.1961
Figure 3: PLR of an individual patient on PCA opioid pain 
control. Time points show the opioid induced decrease in 
pupil diameter and change in pupil response.
Results
A repeated measures ANOVA was conducted to compare the effect of the opioid on specific
parameters of the PLR (GraphPad Prism 7.0c). There was a significant effect of the opioid on the
MAX, MIN, LAT and MCV parameters (Table 1). Dunnett’s test was used to make post hoc
comparisons between each parameter time point and that parameters’ baseline measure. This
test indicated that the 10-minute and 15-minute time points were significantly smaller than the
baseline for the parameters MAX (p=.0016, p=.0010) and MIN (p=.0250, p=.0070). The LAT
parameter was found to be significantly faster from baseline at the 15-minute measure
(p=.0350). 
Tukey’s test was used to make comparisons of each time point to one another and
found that there was a significant difference between the 10-minute and 15-minute time points
for the MIN (p=0.0251)
Table 1: Repeated measures ANOVA evaluating the significance 
of all pupillary parameters baseline vs. post-PCA dosing.
* P-value < 0.05
Figure 1: Using a pupillometer
in a Pediatric Population
